<DOC>
	<DOCNO>NCT02604719</DOCNO>
	<brief_summary>The aim study compare effect low dose Tranexamic acid ( 1gm ) Ethamsylate ( 1gm ) prophylactic oxytocin administration versus placebo prophylactic oxytocin give 2 minute child delivery patient undergo LSCS high risk post partum hemorrhage</brief_summary>
	<brief_title>Tranexamic Acid Ethamsylate For Preventing PPH Patient Undergoing LSCS High Risk For PPH</brief_title>
	<detailed_description>Research Question : Is combination Tranexamic acid Ethamsylate effective oxytocin alone prevent postpartum hemorrhage give delivery fetus ?</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<mesh_term>Ethamsylate</mesh_term>
	<criteria>1 . Women undergo elective caesarean section 2 . Patient one risk factor PPH Multiple pregnancy Polyhydramnios ( AFI &gt; 25cm ) Macrocosmic baby ( &gt; 4.5 Kg ) Prolonged , augment obstructed labour Obese patient ( BMI &gt; 30 ) Premature rapture membranes Previous history PPH 3 . Age ≥18 year 4 . Gestational Age ≥ 35 Weeks 5 . Informed Oral Consent From The Patient 1 . History venous thrombosis ( DVT and/or Pulmonary embolism ) OR arterial thrombosis ( angina pectoris , myocardial infarction , stroke ) 2 . History epilepsy seizure 3 . Any Known Cardiovascular , renal liver Disease 4 . Autoimmune Diseases 5 . Sickle Cell Disease 6 . Severe hemorrhagic Disease 7 . Placenta Previa . 8 . Morbidly adherent Placenta 9 . Abruptio placenta 10 . Eclampsia , hemolysis , elevate liver enzyme , low platelet count syndrome 11 . Administration Of low molecular weight heparin Anti platelets week delivery .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>